Cargando…

Interferons Regulate the Phenotype of  Wild-type and Mutant Herpes Simplex Viruses In Vivo

Mechanisms responsible for neuroattenuation of herpes simplex virus (HSV) have been defined previously by studies of mutant viruses in cultured cells. The hypothesis that null mutations in host genes can override the attenuated phenotype of null mutations in certain viral genes was tested. Mutants s...

Descripción completa

Detalles Bibliográficos
Autores principales: Leib, David A., Harrison, Travis E., Laslo, Kathleen M., Machalek, Michael A., Moorman, Nathaniel J., Virgin, Herbert W.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192939/
https://www.ncbi.nlm.nih.gov/pubmed/9989981
_version_ 1782147353344475136
author Leib, David A.
Harrison, Travis E.
Laslo, Kathleen M.
Machalek, Michael A.
Moorman, Nathaniel J.
Virgin, Herbert W.
author_facet Leib, David A.
Harrison, Travis E.
Laslo, Kathleen M.
Machalek, Michael A.
Moorman, Nathaniel J.
Virgin, Herbert W.
author_sort Leib, David A.
collection PubMed
description Mechanisms responsible for neuroattenuation of herpes simplex virus (HSV) have been defined previously by studies of mutant viruses in cultured cells. The hypothesis that null mutations in host genes can override the attenuated phenotype of null mutations in certain viral genes was tested. Mutants such as those in infected cell protein (ICP) 0, thymidine kinase, ribonucleotide reductase, virion host shutoff, and ICP34.5 are reduced in their capacity to replicate in nondividing cells in culture and in vivo. The replication of these viruses was examined in eyes and trigeminal ganglia for 1–7 d after corneal inoculation in mice with null mutations (−/−) in interferon receptors (IFNR) for type I IFNs (IFN-α/βR), type II IFN (IFN-γR), and both type I and type II IFNs (IFN-α/β/γR). Viral titers in eyes and ganglia of IFN-γR(−/−) mice were not significantly different from congenic controls. However, in IFN-α/βR(−/−) or IFN-α/β/γR(−/−) mice, growth of all mutants, including those with significantly impaired growth in cell culture, was enhanced by up to 1,000-fold in eyes and trigeminal ganglia. Blepharitis and clinical signs of infection were evident in IFN-α/βR(−/−) and IFN-α/β/γR(−/−) but not control mice for all viruses. Also, IFNs were shown to significantly reduce productive infection of, and spread from intact, but not scarified, corneas. Particularly striking was restoration of near-normal trigeminal ganglion replication and neurovirulence of an ICP34.5 mutant in IFN-α/βR(−/−) mice. These data show that IFNs play a major role in limiting mutant and wild-type HSV replication in the cornea and in the nervous system. In addition, the in vivo target of ICP34.5 may be host IFN responses. These experiments demonstrate an unsuspected role for host factors in defining the phenotypes of some HSV mutants in vivo. The phenotypes of mutant viruses therefore cannot be interpreted based solely upon studies in cell culture but must be considered carefully in the context of host factors that may define the in vivo phenotype.
format Text
id pubmed-2192939
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21929392008-04-16 Interferons Regulate the Phenotype of  Wild-type and Mutant Herpes Simplex Viruses In Vivo Leib, David A. Harrison, Travis E. Laslo, Kathleen M. Machalek, Michael A. Moorman, Nathaniel J. Virgin, Herbert W. J Exp Med Articles Mechanisms responsible for neuroattenuation of herpes simplex virus (HSV) have been defined previously by studies of mutant viruses in cultured cells. The hypothesis that null mutations in host genes can override the attenuated phenotype of null mutations in certain viral genes was tested. Mutants such as those in infected cell protein (ICP) 0, thymidine kinase, ribonucleotide reductase, virion host shutoff, and ICP34.5 are reduced in their capacity to replicate in nondividing cells in culture and in vivo. The replication of these viruses was examined in eyes and trigeminal ganglia for 1–7 d after corneal inoculation in mice with null mutations (−/−) in interferon receptors (IFNR) for type I IFNs (IFN-α/βR), type II IFN (IFN-γR), and both type I and type II IFNs (IFN-α/β/γR). Viral titers in eyes and ganglia of IFN-γR(−/−) mice were not significantly different from congenic controls. However, in IFN-α/βR(−/−) or IFN-α/β/γR(−/−) mice, growth of all mutants, including those with significantly impaired growth in cell culture, was enhanced by up to 1,000-fold in eyes and trigeminal ganglia. Blepharitis and clinical signs of infection were evident in IFN-α/βR(−/−) and IFN-α/β/γR(−/−) but not control mice for all viruses. Also, IFNs were shown to significantly reduce productive infection of, and spread from intact, but not scarified, corneas. Particularly striking was restoration of near-normal trigeminal ganglion replication and neurovirulence of an ICP34.5 mutant in IFN-α/βR(−/−) mice. These data show that IFNs play a major role in limiting mutant and wild-type HSV replication in the cornea and in the nervous system. In addition, the in vivo target of ICP34.5 may be host IFN responses. These experiments demonstrate an unsuspected role for host factors in defining the phenotypes of some HSV mutants in vivo. The phenotypes of mutant viruses therefore cannot be interpreted based solely upon studies in cell culture but must be considered carefully in the context of host factors that may define the in vivo phenotype. The Rockefeller University Press 1999-02-15 /pmc/articles/PMC2192939/ /pubmed/9989981 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Leib, David A.
Harrison, Travis E.
Laslo, Kathleen M.
Machalek, Michael A.
Moorman, Nathaniel J.
Virgin, Herbert W.
Interferons Regulate the Phenotype of  Wild-type and Mutant Herpes Simplex Viruses In Vivo
title Interferons Regulate the Phenotype of  Wild-type and Mutant Herpes Simplex Viruses In Vivo
title_full Interferons Regulate the Phenotype of  Wild-type and Mutant Herpes Simplex Viruses In Vivo
title_fullStr Interferons Regulate the Phenotype of  Wild-type and Mutant Herpes Simplex Viruses In Vivo
title_full_unstemmed Interferons Regulate the Phenotype of  Wild-type and Mutant Herpes Simplex Viruses In Vivo
title_short Interferons Regulate the Phenotype of  Wild-type and Mutant Herpes Simplex Viruses In Vivo
title_sort interferons regulate the phenotype of  wild-type and mutant herpes simplex viruses in vivo
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192939/
https://www.ncbi.nlm.nih.gov/pubmed/9989981
work_keys_str_mv AT leibdavida interferonsregulatethephenotypeofwildtypeandmutantherpessimplexvirusesinvivo
AT harrisontravise interferonsregulatethephenotypeofwildtypeandmutantherpessimplexvirusesinvivo
AT laslokathleenm interferonsregulatethephenotypeofwildtypeandmutantherpessimplexvirusesinvivo
AT machalekmichaela interferonsregulatethephenotypeofwildtypeandmutantherpessimplexvirusesinvivo
AT moormannathanielj interferonsregulatethephenotypeofwildtypeandmutantherpessimplexvirusesinvivo
AT virginherbertw interferonsregulatethephenotypeofwildtypeandmutantherpessimplexvirusesinvivo